Pantozol (Pantoprazole)

Pantoprazole, the active ingredient in Pantozol, is a proton pump inhibitor presented as a tablet for oral use. It reduces gastric acid secretion and is prescribed for conditions such as gastroesophageal reflux disease, peptic ulcer disease, and other acid‑related disorders in adults.

GNH USA supplies Pantozol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazole is used to manage acid‑related gastrointestinal conditions. - Gastroesophageal reflux disease (GERD): reduces acid exposure, relieving heartburn and regurgitation. - Erosive esophagitis: promotes healing of inflamed esophageal lining. - Peptic ulcer disease: facilitates ulcer healing and prevents recurrence. - Helicobacter pylori eradication: used as part of combination therapy to eliminate H. pylori infection. - Zollinger‑Ellison syndrome: controls excessive gastric acid production in this rare endocrine disorder.

Pantoprazole may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: loose stools, usually transient. - Nausea: feeling of stomach upset. - Abdominal pain: discomfort in the stomach area. - Flatulence: increased intestinal gas.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis presenting with watery diarrhea. - Acute interstitial nephritis: kidney inflammation with reduced function. - Severe allergic reactions: rash, swelling, or anaphylaxis. - Low magnesium levels: hypomagnesemia causing muscle cramps or arrhythmias.

When prescribing Pantoprazole, clinicians should consider several precautionary measures to ensure safe use. - Assess renal function: dose adjustment may be needed in severe impairment. - Monitor for osteoporosis: long‑term use can affect calcium absorption. - Evaluate for hepatitis C: rare cases of liver injury reported. - Use with caution in pregnancy: category B, but only if benefits outweigh risks. - Review concomitant medications: potential for drug interactions. - Store at room temperature: keep in original container, protect from moisture and heat.

Pantoprazole can alter the pharmacokinetics of several medicines; awareness of key interactions is essential.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, may increase cardiovascular risk. - Atazanavir: decreased absorption, leading to therapeutic failure. - Methotrexate (high dose): increased serum levels, risk of toxicity.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, monitor coagulation. - Digoxin: altered absorption, check serum levels. - Diazepam: increased plasma concentration, observe for sedation. - Iron supplements: reduced absorption, separate dosing by at least 2 hours.